1206529-35-2

Upstream product

• 1206529-34-1 C₂₄H₂₄BrFN₂O₆ 
• 100-39-0 benzyl bromide 
• 1206529-33-0 C₂₇H₃₂BrFN₂O₇ 
• 1206529-32-9 C₂₂H₂₆BrFN₂O₄ 
• 1206529-31-8 C₂₇H₃₄BrFN₂O₆ 
• 156925-79-0 [(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]methyl trifluoromethanesulfonate 
• 14347-78-5 1,2-O-isopropylidene-D-glycerol 

Downstream Products

• 1206529-36-3 C₂₈H₂₆BrFN₂O₆ 
• 1206529-37-4 C₃₇H₄₆BrFN₂O₆Si 
• 1206529-39-6 C₃₇H₄₅FN₂O₆Si 
• 1206529-40-9 C₂₈H₂₅FN₂O₆ 
• 1206529-41-0 C₂₈H₂₃FN₂O₇ 
• 1206529-42-1 C₂₉H₂₆FN₃O₆ 
• 1206529-43-2 C₂₂H₂₀FN₃O₆ 
• 1206526-55-7 C₂₁H₁₉FN₄O₅ 

Relevant academic research and scientific papers

ANTIVIRAL COMPOUNDS

The invention is related to an anti-viral compound of Formula (I), compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compo

ANTIVIRAL COMPOUNDS

The invention is related to anti-viral compounds, compositions containing such compounds, and therapeutic methods that include the administration of such compounds, as well as to processes and intermediates useful for preparing such compounds.